Intrinsic Value of S&P & Nasdaq Contact Us

Phio Pharmaceuticals Corp. PHIO NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
66/100
4/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — PHIO

Phio Pharmaceuticals Corp. (PHIO) has a market capitalization of $14.99M and trades at $1.29. The 52-week range is 0.813-4.19.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.9, Earnings Per Share (EPS) of $-1.45.

The stock has a beta of 0.81, operates in the Healthcare sector.

Trading Data
Current Price$1.29
52-Week Range0.813-4.19
Volume238.29K
Avg Volume (30D)3.86M
Market Cap$14.99M
Beta (1Y)0.81
Company
IPO Date2012-05-10
Employees5
CEORobert J. Bitterman
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS71880W5013
CUSIP71880W303
Income (Latest Year)
Gross Profit$-3K
EBITDA$-9.22M
Operating Income$-9.22M
Net Income$-8.7M
EPS$-1.45
EPS Diluted$-1.45
Shares Outstanding$5.98M
Balance Sheet (Latest Year)
Total Assets$21.49M
Current Assets$21.48M
Cash & ST Investments$21.03M
Total Liabilities$1.34M
Net Debt$-21.03M
Total Equity$20.15M
Valuation Ratios
P/E Ratio-0.9
P/B Ratio0.74
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message